Literature DB >> 1125989

Interaction of BCG-activated macrophages with neoplastic and noneoplastic cell lines in vitro: cinemicrographic analysis.

M S Meltzer, R W Tucker, A C Breuer.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1125989     DOI： 10.1016/s0008-8749(75)80004-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  8 in total

1.  Human monocytes selectively bind to cells expressing the tumorigenic phenotype.

Authors:  H Shimizu; D Wyatt; R D Knowles; C D Bucana; E J Stanbridge; E S Kleinerman
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.

Authors:  J C Drapier; J B Hibbs
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

Review 4.  Tumor cells do not arise frequently.

Authors:  W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Tumour rejection in immunized guinea-pigs.

Authors:  A Kolin; J Vacek; S Landi
Journal:  Br J Exp Pathol       Date:  1983-10

6.  Disruption of oligosaccharide processing in murine tumor cells inhibits their susceptibility to lysis by activated mouse macrophages.

Authors:  A M Mercurio
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.

Authors:  D N Männel; W Falk; M S Meltzer
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells.

Authors:  P A Marino; C C Whisnant; D O Adams
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.